<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Malling Cross | Activity</title>
	<link>https://brycefoster.com/members/switchhorn8/activity/</link>
	<atom:link href="https://brycefoster.com/members/switchhorn8/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Malling Cross.</description>
	<lastBuildDate>Thu, 02 Jul 2026 01:02:47 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">bd0889d662dc51fdfc3630e484a4f4c6</guid>
				<title>Malling Cross posted an update: The Global Landscape of Pharmaceutical Steroids: A Focus on [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1482821/</link>
				<pubDate>Wed, 25 Mar 2026 17:09:06 +0000</pubDate>

									<content:encoded><![CDATA[<p>The Global Landscape of Pharmaceutical Steroids: A Focus on the Russian Market</p>
<p>The pursuit of peak physical performance and aesthetic quality has actually led many athletes, bodybuilders, and fitness enthusiasts to explore the world of Anabolic Androgenic Steroids (AAS). Within this global market, Russia and the surrounding CIS (Commonwealth of&hellip;<span class="activity-read-more" id="activity-read-more-1482821"><a href="https://brycefoster.com/activity/p/1482821/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">dfeef00a9b1eba59e2027e427ad85932</guid>
				<title>Malling Cross became a registered member</title>
				<link>https://brycefoster.com/activity/p/1482741/</link>
				<pubDate>Wed, 25 Mar 2026 16:56:17 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>